BookMarc H V Van Regenmortel.
Summary: This book gathers a series of pivotal papers on the development of an HIV/AIDS vaccine published in the last two decades. Accompanied by extensive comments putting the material into an up-to-date context, all three parts of the book offer a broad overview of the numerous unsuccessful attempts made in recent years to develop a preventive HIV vaccine. Providing a detailed review and analysis of studies published from 1998 to the present day, it examines the likely reasons for the failure to develop an HIV vaccine despite multi-million dollar investments.
Contents:
Part I.Immunochemistry
1 What is a B cell epitope
2 Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology
3 Synthetic Peptide Vaccines and the Search for Neutralization B Cell Epitopes
4 Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition
Part II. Reductionism
5 Reductionism and the search for structure-function relationships in antibody molecules
6 Reductionism and complexity in molecular biology
7 Editorial: Biological complexity emerges from the ashes of genetic reductionism
8 The rational design of biological complexity: A deceptive metaphor., 9 Basic research in HIV vaccinology is hampered by reductionist thinking
10 Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
11 Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases., Part III. Vaccinology
12 Limitations to the structure-based design of HIV-1 vaccine immunogens
13 Two meanings of reverse vaccinology and the empirical nature of vaccine science
14 Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
15 Paradigm Changes and the Future of HIV Vaccine Research: A Summary of a Workshop Held in Baltimore on 20 November 2013
16 Editorial: Paradigm changes are required in HIV vaccine research
17 An outdated notion of antibody specificity is one of the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from helping to develop an effective HIV-1 vaccine
18 More surprises in the development of an HIV vaccine
19 Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
20 Old a nd New Concepts and Strategies in HIV Vaccinology: A Report from a Workshop held in Rome on 17 June 2016
21 Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory
22 Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV
23 Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
24 Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia?.